Clinical Approach to Penile Implant Selection for Physicians

In brief: Penile implant selection cannot be reduced to ranking catalogue features or promoting a single technical attribute. The indication and the person’s clinical goals are defined first; anatomy, previous surgery, manual dexterity, device operation, official product documentation, and the institution’s operating-room and follow-up capacity are then considered together. Product information supports this decision, but patient selection and the final device decision remain the responsibility of the trained specialist physician.

Start with the clinical question, not the device

The context includes the cause, duration, and severity of erectile dysfunction; whether previous treatments were used correctly; penile curvature or fibrosis; diabetes and cardiovascular or neurological conditions; active infection risk; and previous pelvic or abdominal surgery. The current EAU guideline considers penile prosthesis when other treatments fail or according to informed patient preference. A category discussion therefore cannot replace a proper penile implant candidacy assessment. ^[1]

The objective is not to select the device that appears most advanced. It is to establish a defensible fit among safe use, realistic expectations, and sustainable follow-up. Expectations about sensation, orgasm, ejaculation, penile length, and existing anatomical constraints should be discussed separately. The implant provides mechanical rigidity; it should not be assumed to directly treat every other aspect of sexual function.

How are inflatable and malleable categories assessed?

Inflatable systems

Two- or three-piece inflatable systems contain cylinders and a pump; three-piece configurations also include a reservoir. The person must be able to locate and operate the pump and understand inflation and deflation. Hand strength and coordination, previous abdominal or pelvic surgery, anatomy, and access to product-specific education and follow-up all matter. This resource does not prescribe a surgical approach.

Malleable systems

Malleable implants have no pump or reservoir and are positioned manually. Mechanical simplicity is not automatic superiority. Persistent rigidity, positioning, pressure, concealment, tissue condition, and day-to-day expectations still require clinical discussion.

The EAU notes that current evidence does not establish general efficacy or safety superiority among implant or surgical-approach options and treats comprehensive counselling as part of device selection. Category differences are patient- and institution-specific decision domains, not a marketing hierarchy. ^[1]

Where is the clinical–technical boundary?

Indication, clinical interpretation of contraindications, anatomical suitability, patient goals, and the surgical plan are clinical responsibilities. Confirming product codes, locating the correct components and current instructions for use, and making MR, sterility, or compatibility information accessible are documentation and institutional-readiness responsibilities. Technical support does not replace clinical judgement, and the clinical team should not fill an uncertain product identity by assumption.

A product code, model name, packaging level, and UDI are not interchangeable. The European Commission explains that the UDI-DI identifies a specific device model or variation, while the Basic UDI-DI connects a device group in relevant documentation. A family name in a catalogue therefore does not prove the identity of the component in hand. ^[2]

How is official literature matched to the product?

Document control involves more than reading the PDF title. Manufacturer, product family, model/reference or catalogue code, document number, revision or publication date, language, and intended market should be compared. Boston Scientific’s eLabeling portal instructs users to use literature from the region where the procedure is performed and to review the literature before using or implanting a device or providing follow-up care. ^[3]

A brochure may introduce a product family. For intended purpose, contraindications, warnings, component compatibility, preparation, sterility, or MR conditions, the current official IFU or other controlled product-specific literature governs. The AMS 700 operating-room manual, for example, describes components and processes for that system and revision; it cannot automatically be generalised to another product. ^[4]

The practical steps are set out in the medical device documentation guide. When information is missing or conflicts, the safer response is to state the identifiers and the document needed, then request verification rather than inferring from the family name.

What belongs in the institutional decision record?

• The clinical rationale and evidence that alternatives were considered.
• A clear distinction between the selected product family and individual product/component codes.
• The document number, revision, language, and market scope of the IFU or controlled literature used.
• Access to applicable warnings, contraindications, compatibility, sterility, and MR information.
• Team competence, product-specific preparation, patient education, implant records, and follow-up responsibilities.
• Who resolved each uncertainty, using which authoritative source and on what date.

This record does not transfer clinical responsibility to procurement or field support. It helps reduce the risk of using literature for the wrong model, relying on an obsolete revision, or treating information prepared for another market as locally applicable.

How do the three physician resources work together?

This article establishes the clinical–technical selection boundary. Use the technical documentation guide for product-to-document matching and the product enquiry and technical-support guide to frame questions for a manufacturer or technical channel. Luvi’s existing technical documentation area provides a product-literature context; it does not make device recommendations for an individual patient.

Frequently asked questions

Does manual dexterity determine the category on its own?

No. Dexterity and learning capacity are important functional inputs, but they are considered alongside anatomy, previous surgery, clinical goals, the care pathway, and informed preference.

Is a product brochure sufficient for the decision?

No. A brochure can be introductory. Current official IFU or controlled manufacturer literature is needed for product-specific intended purpose, warnings, contraindications, compatibility, and conditions of use.

What responsibility can technical support assume?

Technical support may clarify product identity and access to documentation. Indication, patient selection, clinical interpretation, and surgical decisions remain with qualified healthcare professionals and the institution.

Professional boundary

This resource does not recommend a particular implant, claim universal compatibility, or teach surgical technique. Diagnosis, patient and device selection, implantation, and follow-up must be managed by a trained specialist and qualified institution using current official product information. An institutional document or product question can be structured without identifiable patient data through the Luvi contact channel; this is not a commitment regarding a particular service, stock, delivery, or training programme.

References

1. EAU Guidelines on Sexual and Reproductive Health: Management of Erectile Dysfunction, current online edition.
2. European Commission, Unique Device Identifier — UDI.
3. Boston Scientific eLabeling portal.
4. Boston Scientific, AMS 700 with MS Pump Operating Room Manual. Current, market-applicable product IFU remains controlling.